Table 1.
Baseline characteristics.
| Overall Population (n = 109) | IC Group (n = 89) | PP group (n = 20) | p Value | |
|---|---|---|---|---|
| Baseline characteristics | ||||
| Age, years | 64.7 ± 11.1 | 65.1 ± 11.4 | 63.3 ± 9.5 | 0.51 |
| BMI, kg/m2 | 26.1 ± 4.8 | 26.1 ± 5.0 | 26.3 ± 4.3 | 0.83 |
| Female, n (%) | 56 (51.4) | 43 (48.3) | 13 (65.0) | 0.18 |
| Medical therapy for PH, n (%) | 104 (95.4) | 84 (94.4) | 20 (100.0) | 0.62 |
| Underlying medial conditions, n (%) | ||||
| Previous PE | 57 (52.3) | 46 (51.7) | 11 (55.0) | 0.79 |
| VC filter | 4 (3.7) | 1 (1.1) | 3 (15.0) | 0.02 |
| Hypertension | 29 (26.6) | 24 (27.0) | 5 (25.0) | 0.86 |
| Dyslipidaemia | 4 (3.7) | 4 (4.5) | 0 | 0.76 |
| Thrombophilia disorder | 11 (10.1) | 10 (11.2) | 1 (5.0) | 0.67 |
| Gynaecological disorder | 13 (11.9) | 11 (12.4) | 2 (10.0) | 0.93 |
| Thyroid disorder | 17 (15.6) | 12 (13.5) | 5 (25.0) | 0.35 |
| Psychiatric disorder | 13 (11.9) | 9 (10.1) | 4 (20.0) | 0.39 |
| Cancer | 17 (15.6) | 13 (14.6) | 4 (20.0) | 0.80 |
| Splenectomy | 17 (15.6) | 15 (16.9) | 2 (10.0) | 0.67 |
| Exercise and QoL at baseline | ||||
| 6‐MWD, m | 350.9 ± 116.3 | 350.3 ± 115.2 | 353.3 ± 125.3 | 0.93 |
| WHO FC (I/II/III/IV), n | 0/35/73/1 | 0/30/58/1 | 0/5/15/0 | 0.62 |
| CAMPHOR symptom score | 10.3 ± 5.7 | 10.7 ± 5.6 | 8.5 ± 5.6 | 0.12 |
Note: Continuous data are presented as mean ± SD, whilst discrete data are presented as data counts (%).
Abbreviations: 6‐MWD, 6 min walk distance; BMI, body mass index; CAMPHOR, Cambridge Pulmonary Hypertension Outcome Review; PE, pulmonary embolism; VC, vena cava; WHO FC, World Health Organization Functional Class.